Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

VASCULAR THERAPY : revenue, balance sheet and financial ratios

VASCULAR THERAPY is a French company founded 16 years ago, specialized in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques. Based in PARIS (75010), this company of category PME shows in 2022 a revenue of 4.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - VASCULAR THERAPY (SIREN 513172148)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017
Revenue N/C N/C 3 974 816 € N/C N/C N/C N/C N/C
Net income 52 225 € -246 518 € 21 439 € 31 882 € -42 497 € 34 527 € 24 762 € 27 625 €
EBITDA N/C N/C 7 503 € N/C N/C N/C N/C N/C
Net margin N/C N/C 0.5% N/C N/C N/C N/C N/C

Revenue and income statement

In 2024, VASCULAR THERAPY generates positive net income of 52 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 28 k€ -> 52 k€.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

52 225 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -5%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-5.115%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

66.5%

Solvency indicators evolution
VASCULAR THERAPY

Sector positioning

Debt ratio
0.0 2024
2022
2023
2024
Q1: 0.0
Med: 5.8
Q3: 35.12
Excellent -50 pts over 3 years

In 2024, the debt ratio of VASCULAR THERAPY (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-5.12% 2024
2022
2023
2024
Q1: 15.09%
Med: 44.33%
Q3: 67.75%
Watch

In 2024, the financial autonomy of VASCULAR THERAPY (-5.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Repayment capacity
-9.59 years 2022
2022
Q1: 0.0 years
Med: 0.0 years
Q3: 1.34 years
Excellent

In 2022, the repayment capacity of VASCULAR THERAPY (-9.59) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 83.31. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

83.308

Liquidity indicators evolution
VASCULAR THERAPY

Sector positioning

Liquidity ratio
83.31 2024
2022
2023
2024
Q1: 144.96
Med: 248.4
Q3: 435.6
Watch -7 pts over 3 years

In 2024, the liquidity ratio of VASCULAR THERAPY (83.31) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
92.96x 2022
2022
Q1: 0.0x
Med: 0.0x
Q3: 1.59x
Excellent

In 2022, the interest coverage of VASCULAR THERAPY (93.0x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
VASCULAR THERAPY

Positioning of VASCULAR THERAPY in its sector

Comparison with sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Valuation estimate

Based on 50 transactions of similar company sales (all years), the value of VASCULAR THERAPY is estimated at 83 786 € (range 58 421€ - 287 588€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
50 tx
58k€ 83k€ 287k€
83 786 € Range: 58 421€ - 287 588€
NAF 5 all-time

Valuation method used

Net Income Multiple
52 225 € × 1.6x = 83 787 €
Range: 58 422€ - 287 589€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 50 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Intermédiaires spécialisés dans le commerce d'autres produits spécifiques)

Compare VASCULAR THERAPY with other companies in the same sector:

Voir toutes les statistiques du secteur Intermédiaires spécialisés dans le commerce d'autres produits spécifiques

Frequently asked questions about VASCULAR THERAPY

What is the revenue of VASCULAR THERAPY ?

The revenue of VASCULAR THERAPY in 2022 is 4.0 M€.

Is VASCULAR THERAPY profitable?

Yes, VASCULAR THERAPY generated a net profit of 52 k€ in 2024.

Where is the headquarters of VASCULAR THERAPY ?

The headquarters of VASCULAR THERAPY is located in PARIS (75010), in the department Paris.

Where to find the tax return of VASCULAR THERAPY ?

The tax return of VASCULAR THERAPY is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does VASCULAR THERAPY operate?

VASCULAR THERAPY operates in the sector Intermédiaires spécialisés dans le commerce d'autres produits spécifiques (NAF code 46.18Z). See the 'Sector positioning' section above to compare the company with its competitors.